Is AbbVie's High Dividend Safe? ABBV Stock Analysis episode artwork

EPISODE · Oct 23, 2021 · 7 MIN

Is AbbVie's High Dividend Safe? ABBV Stock Analysis

from Collect Cash · host CitizenOfTheYear

Abbvie ABBV Stock continues to remain a favorite of dividend investors because of it's high dividend yield as well as chances for some amazing capital appreciation. In today's video I go over Abbvie Pharmaceutical's business model and if their products will be in demand even after their patents expire. Abbvie's strong cash flow from its diversified product line continue to be able to fund it's high dividend yield. Abbvie has an impressive 5 year dividend growth rate of nearly 17% and has seen its share price rise considerably in the past 5 years. I also talk about some of their next in line products that will provide cash flow for the foreseeable future. Follow me on YouTube: CitizenoftheYear! Catch me where ever you get your podcast! Collect Cash Podcast!  Disclaimer:This is not financial advice and I am not a licensed financial advisor. Always do your own research before investing and work with a licensed financial advisor. These are my opinions for informational purposes only and not to be taken as investing advice.

Episode metadata supplied by the publisher feed · Published Oct 23, 2021

Embed this episode

NOW PLAYING

Is AbbVie's High Dividend Safe? ABBV Stock Analysis

0:00 7:37

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Collect Cash?

This episode is 7 minutes long.

When was this Collect Cash episode published?

This episode was published on October 23, 2021.

Can I download this Collect Cash episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!